Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
IR-Med, Inc. (IRME) had Stock-Based Compensation of $0.05M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-0.77M |
|
-- |
|
-- |
|
$0.25M |
|
$-0.25M |
|
$-0.52M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.77M |
|
$-0.25M |
|
$-0.25M |
|
71.26M |
|
71.26M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.08M |
|
$0.03M |
|
$0.04M |
|
$0.12M |
|
$0.62M |
|
-- |
|
-- |
|
$0.62M |
|
$-0.49M |
|
$-0.49M |
|
$-0.49M |
|
72.01M |
|
| Cash Flow Statement Financials | |
$-0.11M |
|
-- |
|
$0.03M |
|
$0.13M |
|
$0.05M |
|
$-0.08M |
|
|
Stock-Based Compensation |
$0.05M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.13 |
|
-- |
|
-- |
|
-- |
|
-0.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
156.80% |
|
156.80% |
|
-623.39% |
|
156.80% |
|
$-0.01 |
|
$-0.00 |
|
$-0.00 |
|